Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Study Identifier
P12-672
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Axial Spondyloarthritis (axSpA)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years

    Protocol Summary

    The current study will assess the real - life effectiveness of adalimumab in the management of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of extra-articular manifestations.

    Study Locations

    Location
    Status
    Location
    Rheumatology Clinic /ID# 54768
    Calgary, Alberta, Canada, T2P 0V2
    Status
    Not applicable
    Location
    Associate Clinic /ID# 64274
    Calgary, Alberta, Canada, T2P 3C5
    Status
    Not applicable
    Location
    Pont, Cranbrook, BC, CA /ID# 55242
    Cranbrook, British Columbia, Canada, V1C 2R7
    Status
    Not applicable
    Location
    Dr. Barbara T. Blumenauer Inc. /ID# 55226
    Kamloops, British Columbia, Canada, V2C 0B8
    Status
    Not applicable
    Location
    Hudson, Kamloops, Canada /ID# 54577
    Kamloops, British Columbia, Canada, V2C 6G6
    Status
    Not applicable
    Location
    Dr. Maqbool R. Sheriff Inc. /ID# 55247
    Nanaimo, British Columbia, Canada, V9S 4S1
    Status
    Not applicable
    Showing {first} - {last} of {total} Results